Michel Jourdan

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Michel Jourdan, Anouk Caraux, John De Vos et al. · Blood · 2009 · 238 citations · Full text

JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

John De Vos, Michel Jourdan, Karin Tarte et al. · British Journal of Haematology · 2000 · 172 citations

Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays

John De Vos, Thomas Thykjær, Karin Tarte et al. · Oncogene · 2002 · 169 citations

Oligonucleotide Arrays, Medicine, Cancer Genomics +9

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

Anne Catherine Sprynski, Dirk Hose, L. Caillot et al. · Blood · 2009 · 164 citations · Full text

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

John De Vos, Guilhem Couderc, Karin Tarte et al. · Blood · 2001 · 159 citations